Zhen Li is VP at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). They have made 1 open-market trade across 1 company since 2019, most recently 2019-01-14.
CIK 0001729510
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARWR | 201,700 | $11.3M |
Shares reported on the most recent Form 4, priced at the 2019-01-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARWR | SELL | 2019-01-14 | 2019-01-16 | $14.34 | $581K | -8.5% | +24.2% | +33.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.